News & Events
-
-
Press Announcements
-
-
Note: Press announcements from 2004 to 2009 are available through the FDA Archive. Some links in press announcements may no longer be active. For more information, contact FDA’s Office of Media Affairs at 301-796-4540.
-
May 2013
- May 23, 2013 - FDA allows marketing of first A1c test labeled for diagnosing diabetes
- May 18, 2013 - FDA expands alert to health care providers about lack of sterility assurance of all sterile drug products from NuVision Pharmacy
- May 17, 2013 - FDA seeks preliminary injunction against New York fish manufacturer
- May 15, 2013 - FDA approves Simponi to treat ulcerative colitis
- May 15, 2013 - La FDA aprueba nuevo medicamento para el cáncer de próstata avanzado
- May 15, 2013 - FDA approves new drug for advanced prostate cancer
- May 14, 2013 - FDA approves Nymalize--first nimodipine oral solution for use in certain brain hemorrhage patients
- May 14, 2013 - FDA approves first companion diagnostic to detect gene mutation associated with a type of lung cancer
- May 13, 2013 - FDA releases new tool to help prevent intentional food contamination
- May 10, 2013 - FDA warns consumers about potential health risk with Juices Incorporated juice products
- May 10, 2013 - FDA approves Breo Ellipta to treat chronic obstructive pulmonary disease
- May 08, 2013 - FDA alerts health care providers of lack of sterility assurance of drug products from The Compounding Shop
- May 06, 2013 - FDA issues proposal to increase consumer awareness of tanning bed risks
- May 06, 2013 - FDA warns pregnant women to not use certain migraine prevention medicines
- May 06, 2013 - La FDA advierte a mujeres embarazadas que no usen ciertos medicamentos para prevenir migrañas
-
April 2013
- April 30, 2013 - FDA approves Plan B One-Step emergency contraceptive without a prescription for women 15 years of age and older
- April 30, 2013 - FDA approves Procysbi for rare genetic condition
- April 29, 2013 - FDA approves Kcentra for the urgent reversal of anticoagulation in adults with major bleeding
- April 24, 2013 - FDA launches partnership to protect against counterfeit anti-malarial medicines with FDA-developed handheld detection tool
- April 24, 2013 - La FDA se asocia con otras organizaciones para la protección contra medicamentos antipalúdicos falsos a través del uso de un aparato portátil para la detección y desarrollado por la FDA
- April 21, 2013 - FDA announces voluntary nationwide recall by Balanced Solutions Compounding Pharmacy
- April 16, 2013 - FDA approves abuse-deterrent labeling for reformulated OxyContin
- April 15, 2013 - FDA issues alert about lack of sterility assurance of drug products from ApotheCure, Inc. and NuVision Pharmacy and of forthcoming recall
- April 15, 2013 - FDA: U.S. Marshals seize food at New York-based food facility
- April 10, 2013 - FDA budget requests $4.7 billion to ensure safety of food supply and to modernize medical product safety
- April 08, 2013 - La FDA aprueba Diclegis para las mujeres embarazadas que experimentan náuseas y vómitos
- April 08, 2013 - FDA approves Diclegis for pregnant women experiencing nausea and vomiting
-
March 2013
- March 29, 2013 - FDA approves Invokana to treat type 2 diabetes
- March 27, 2013 - FDA approves new multiple sclerosis treatment: Tecfidera
- March 22, 2013 - La FDA aprueba la primera antitoxina contra el botulismo para neutralizar todos los siete serotipos conocidos de la neurotoxina botulínica.
- March 22, 2013 - FDA approves first Botulism Antitoxin for use in neutralizing all seven known botulinum nerve toxin serotypes
- March 22, 2013 - FDA approves TOBI Podhaler to treat a type of bacterial lung infection in cystic fibrosis patients
- March 22, 2013 - FDA issues proposal to improve the quality of automated external defibrillators
- March 21, 2013 - FDA alerts health care providers and patients of the nationwide recall of all lots of sterile products distributed by Clinical Specialties Compounding Pharmacy
- March 20, 2013 - FDA approves Dotarem, a new magnetic resonance imaging agent
- March 18, 2013 - FDA alerts health care providers of recall of all sterile drug products by Med Prep Consulting in New Jersey
- March 18, 2013 - FDA warns consumers not to eat certain ProtiDiet High Protein Chocolate Dream Bars manufactured by Pro-Amino International, Inc., Quebec, Canada
- March 13, 2013 - FDA approves Lymphoseek to help locate lymph nodes in patients with certain cancers
- March 13, 2013 - Federal judge approves consent decree with New Jersey bakery
- March 08, 2013 - FDA issues draft guidance for manufacturers to accurately label medical products that are not made with natural rubber latex
-
February 2013
- February 26, 2013 - La FDA aprueba Osphena para mujeres postmenopáusicas que sufren dolor durante el acto sexual
- February 26, 2013 - FDA approves Osphena for postmenopausal women experiencing pain during sex
- February 25, 2013 - FDA approves Stivarga for advanced gastrointestinal stromal tumors
- February 24, 2013 - FDA alerts health care providers of recall of anemia drug Omontys
- February 22, 2013 - FDA enters into consent decree with Chicago sprout producer due to unsanitary conditions
- February 22, 2013 - La FDA aprueba un nuevo tratamiento para el cáncer de mama en etapa avanzada
- February 22, 2013 - FDA approves new treatment for late-stage breast cancer
- February 21, 2013 - Kasel Associates Industries recalling certain pet treats due to Salmonella contamination
- February 20, 2013 - FDA approves new silicone breast implant
- February 20, 2013 - FDA seeks input on minimizing disruptions to medical device supply chain during extreme weather events
-
-
-
-
